MedPath

To check irritation potential of the given samples (Patch test)

Phase 2
Completed
Conditions
Skin patch test
Registration Number
CTRI/2013/04/003579
Lead Sponsor
ITC R and D CENTRE
Brief Summary

Skin Irritation Test:

Irritants are substances that damage the skin. The damage will depend upon the nature, concentration and duration of exposure. Irritation is manifested as inflammatory responses such as erythema (redness), Oedema (swelling), and vesiculation and finally to an intense suppurate reaction without the involvement of the immune system. The irritation potential of a substance can be assessed by human patch test.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
24
Inclusion Criteria

Is a female/ male in generally good health,Is between the ages of 18 and 50 years,Has not participated in a similar clinical investigation in the past four weeks,Is willing to give a written informed consent and come for regular observation.

Exclusion Criteria

A known history or present condition of allergic response to any cosmetic products,Skin disease (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations on the scalp), which would interfere with the test readings,Medications (e.g. steroids or antihistamines), which would compromise the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
irritation potentialOn each subject’s back one patch of each investigational product will be applied on Day 1. This will be 9 days study. For all the products and positive control the subjects will be assessed by the study dermatologist on Day 1 (Day of patch application), Day 2 (0 hrs. of patch removal i.e. 24 hrs. of patch application), Day 3 (24 hrs. of patch removal) and Day 9 (1 week after patch removal).
Secondary Outcome Measures
NameTimeMethod
Investigational products to be tested for irritancy testOn each subject’s back one patch of each investigational product will be applied on Day 1. This will be 9 days study. For all the products and positive control the subjects will be assessed by the study dermatologist on Day 1 (Day of patch application), Day 2 (0 hrs. of patch removal i.e. 24 hrs. of patch application), Day 3 (24 hrs. of patch removal) and Day 9 (1 week after patch removal).

Trial Locations

Locations (1)

The KETs Scientific research centre, Cosmetology division

🇮🇳

(Suburban), MAHARASHTRA, India

The KETs Scientific research centre, Cosmetology division
🇮🇳(Suburban), MAHARASHTRA, India
Ms Yamini Patil
Principal investigator
022-25639644
yamini@kelkarcosmetology.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.